247 related articles for article (PubMed ID: 22544183)
1. Are countries using global fund support to implement HIV drug resistance surveillance? A review of funded HIV grants.
Kelley KF; Caudwell E; Xueref S; Ha TH; Bertagnolio S
Clin Infect Dis; 2012 May; 54 Suppl 4():S250-3. PubMed ID: 22544183
[TBL] [Abstract][Full Text] [Related]
2. Global Fund investments in harm reduction from 2002 to 2009.
Bridge J; Hunter BM; Atun R; Lazarus JV
Int J Drug Policy; 2012 Jul; 23(4):279-85. PubMed ID: 22421551
[TBL] [Abstract][Full Text] [Related]
3. Global fund financing of tuberculosis services delivery in prisons.
Lee D; Lal SS; Komatsu R; Zumla A; Atun R
J Infect Dis; 2012 May; 205 Suppl 2():S274-83. PubMed ID: 22448026
[TBL] [Abstract][Full Text] [Related]
4. [The Global Fund to fight HIV/AIDS, TB and Malaria 5-y: evaluation policy issues].
Kerouedan D
Bull Soc Pathol Exot; 2010 May; 103(2):119-22. PubMed ID: 20376595
[TBL] [Abstract][Full Text] [Related]
5. The World Health Organization's global strategy for prevention and assessment of HIV drug resistance.
Bennett DE; Bertagnolio S; Sutherland D; Gilks CF
Antivir Ther; 2008; 13 Suppl 2():1-13. PubMed ID: 18578063
[TBL] [Abstract][Full Text] [Related]
6. An analysis of GAVI, the Global Fund and World Bank support for human resources for health in developing countries.
Vujicic M; Weber SE; Nikolic IA; Atun R; Kumar R
Health Policy Plan; 2012 Dec; 27(8):649-57. PubMed ID: 22333685
[TBL] [Abstract][Full Text] [Related]
7. [The Global Fund to fight HIV/AIDS, TB and malaria policy issues].
Kerouedan D
Med Trop (Mars); 2010 Feb; 70(1):19-27. PubMed ID: 20337110
[TBL] [Abstract][Full Text] [Related]
8. Factors influencing performance of Global Fund-supported tuberculosis grants.
Katz I; Aziz MA; Olszak-Olszewski M; Komatsu R; Low-Beer D; Atun R
Int J Tuberc Lung Dis; 2010 Sep; 14(9):1097-103. PubMed ID: 20819253
[TBL] [Abstract][Full Text] [Related]
9. World Health Organization surveys to monitor HIV drug resistance prevention and associated factors in sentinel antiretroviral treatment sites.
Jordan MR; Bennett DE; Bertagnolio S; Gilks CF; Sutherland D
Antivir Ther; 2008; 13 Suppl 2():15-23. PubMed ID: 18575188
[TBL] [Abstract][Full Text] [Related]
10. Absorptive capacity and disbursements by the Global Fund to Fight AIDS, Tuberculosis and Malaria: analysis of grant implementation.
Lu C; Michaud CM; Khan K; Murray CJ
Lancet; 2006 Aug; 368(9534):483-8. PubMed ID: 16890835
[TBL] [Abstract][Full Text] [Related]
11. Global Fund needs $15bn to fight HIV, tuberculosis, and malaria.
Gulland A
BMJ; 2013 Sep; 347():f5601. PubMed ID: 24037858
[No Abstract] [Full Text] [Related]
12. The Global Fund 2001-2006: a review of the evidence.
Feachem R; Sabot O
Glob Public Health; 2007; 2(4):325-41. PubMed ID: 19283631
[TBL] [Abstract][Full Text] [Related]
13. Ugandan AIDS care workers realign strategies as Global Fund cuts grants.
Wasswa H
BMJ; 2011 Dec; 343():d8018. PubMed ID: 22155661
[No Abstract] [Full Text] [Related]
14. Operational and implementation research within Global Fund to Fight AIDS, Tuberculosis and Malaria grants: a situation analysis in six countries.
Kiefer S; Knoblauch AM; Steinmann P; Barth-Jaeggi T; Vahedi M; Maher D; Utzinger J; Wyss K
Global Health; 2017 Mar; 13(1):22. PubMed ID: 28340619
[TBL] [Abstract][Full Text] [Related]
15. World Health Organization/HIVResNet Drug Resistance Laboratory Strategy.
Bertagnolio S; Derdelinckx I; Parker M; Fitzgibbon J; Fleury H; Peeters M; Schuurman R; Pillay D; Morris L; Tanuri A; Gershy-Damet GM; Nkengasong J; Gilks CF; Sutherland D; Sandstrom P
Antivir Ther; 2008; 13 Suppl 2():49-57. PubMed ID: 18575191
[TBL] [Abstract][Full Text] [Related]
16. The role of the Technical Review Panel of the Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria: an analysis of grant recommendations.
Schmidt-Traub G
Health Policy Plan; 2018 Apr; 33(3):335-344. PubMed ID: 29309574
[TBL] [Abstract][Full Text] [Related]
17. The impact of Global Health Initiatives at national and sub-national level - a policy analysis of their role in implementation processes of antiretroviral treatment (ART) roll-out in Zambia and South Africa.
Hanefeld J
AIDS Care; 2010; 22 Suppl 1():93-102. PubMed ID: 20680864
[TBL] [Abstract][Full Text] [Related]
18. The Global Fund to Fight AIDS, Tuberculosis and Malaria's investments in harm reduction through the rounds-based funding model (2002-2014).
Bridge J; Hunter BM; Albers E; Cook C; Guarinieri M; Lazarus JV; MacAllister J; McLean S; Wolfe D
Int J Drug Policy; 2016 Jan; 27():132-7. PubMed ID: 26342275
[TBL] [Abstract][Full Text] [Related]
19. Global fund signs major new AIDS and TB grants for India.
Rassool GH
J Adv Nurs; 2004 Jun; 46(6):671-2. PubMed ID: 15188782
[No Abstract] [Full Text] [Related]
20. Critical interactions between Global Fund-supported programmes and health systems: a case study in Lao People's Democratic Republic.
Mounier-Jack S; Rudge JW; Phetsouvanh R; Chanthapadith C; Coker R
Health Policy Plan; 2010 Nov; 25 Suppl 1():i37-42. PubMed ID: 20966107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
